Request a Report Request a Demo

Make Better Underwriting Decisions Amid the COVID-19 Pandemic

This webinar was featured live February 3 and 4, 2021.
Please register to view the recording.


The COVID-19 pandemic is adding unprecedented complexity to underwriting, and insurers are under pressure to adapt. Join us for a review of the latest COVID-19-related developments on vaccines, medications, severity indicators, and interpretation tools so you can better assess individual risk and make informed underwriting decisions.

Topics covered

    • COVID-19 treatments
    • Risk factors for severe cases and post-acute COVID-19 syndrome
    • Vaccination strategies and implications
    • An Irix enhancement that automatically groups electronic health data into specific conditions
    • Examples that illustrate the differences in mild and severe COVID-19 cases

Who should attend

This session is intended for medical directors, underwriters, and other clinical and insurance professionals who want to heighten their understanding and interpretation of COVID-19 risks.


Scott Coller, PharmD

Product Manager, Medical Data, Milliman IntelliScript

Dan Fleischman, PharmD, BCPS

Manager, Clinical Services, Milliman IntelliScript